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ABSTRACT Despite the finding that the hemin-controlled
translational inhibitor in reticulocyte lysates is a cyclic AMP-
independent protein kinase that phosphorylates the small sub-
unit of the initiation factor eIF-2, the mechanism of inhibition
of translation remained unexplained. Whereas treatment of
hemin-containing lysates with inhibitor in the presence of ATP
inhibited translation, the same treatment of highly purified
eIF-2 did not affect its ability to form a ternary complex with
initiator Met-tRNA and GTP or a 40S initiation complex. We
have isolated from ribosomal salt washes a protein (eIF-2
stimulating protein) that enhances the capacity of unphospho-
rylated eIF-2 to form ternary or 40S initiation complexes but has
no effect on the phosphorylated factor. At low concentrations,
eIF-2 is virtually inactive without this stimulating protein.
Therefore, the translational inhibitor acts by converting eIF-2
to a form that is not stimulated by the stimulating protein.
In reticulocytes and other eukaryotic cells the initiator species
of eukaryotic Met-tRNA (Met-tRNAj) binding factor eIF-2 is
rendered inactive for polypeptide chain initiation by phos-
phorylation of its small subunit. This reaction is catalyzed (1-4),
in the presence of ATP, by an adenosine 3',5'-cyclic mono-
phosphate (cAMP)-independent protein kinase (active eIF-2
kinase, inhibitor) and there is evidence (5-7) that the active
enzyme arises by phosphorylation of an inactive precursor
(inactive eIF-2 kinase, proinhibitor) catalyzed by cAMP-de-
pendent protein kinase. Hemin prevents the proinhibitor-
inhibitor conversion (8) because it blocks the activation of
cAMP-dependent protein kinase by cAMP (6, 7) through
binding to the regulatory subunit of the enzyme (unpublished
data). eIF-2 forms a ternary complex with Met-tRNAj and GTP
which, upon binding to a 40S ribosomal subunit, gives rise to
a 40S initiation complex. This sets the stage for elongation of
the polypeptide chain.
In the presence of inhibitor and ATP, the rate of protein
synthesis in hemin-containing reticulocyte lysates soon shows
a sharp decline (9). Although this effect would appear to be
related to the phosphorylation of eIF-2, treatment of purified
eIF-2 with inhibitor plus ATP does not interfere with its ability
to form ternary or 40S initiation complexes (1, 5, 10). On the
other hand, formation of the complex is impaired when par-
tially purified eIF-2 is used (5, 10). This suggests that inhibition
of translation involves another factor(s) present in lysates and
in partially purified eIF-2 preparations. Ribosomal salt washes
contain, along with eIF-2, a factor(s) necessary for inhibition
of ternary complex formation when purified eIF-2 is treated
with inhibitor and ATP. The new factor enhances the ability
of unphosphorylated eIF-2 to form ternary or 40S initiation
complexes but has no effect on phosphorylated eIF-2; it will be
referred to as the eIF-2 stimulating protein (ESP). At the low
concentrations present in reticulocyte lysates, eIF-2 is virtually
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inactive without ESP. Thus, the hemin-controlled translational
inhibitor acts by abolishing the stimulating effect of ESP.
MATERIALS AND METHODS
Assays. Ternary complex formation was assayed as described
(11) with A. salina [35S]Met-tRNAj (specific radioactivity,
19,000-11,000 cpm/pmol), 1.5-3 pmol; GTP, 0.14 mM; and
eIF-2 and/or ESP, as specified in the legends. The translational
inhibitor, eIF-2 kinase (referred to throughout this paper as the
inhibitor) was assayed routinely through its inhibition of ternary
complex formation (5) by ESP-containing eIF-2, in the presence
of ATP. Fig. I shows the inhibition as a function of either in-
hibitor or ATP. Note that there was no inhibition in the absence
of added ATP and that 0.05-0.1 mM ATP saturated the system
(Fig. 1B). For comparison with other preparations of inhibitor
(12) we used the protein synthesis assay (5). ESP was determined
with the ternary complex assay.
We suspected that ribosomal washes contained a factor(s)
necessary for inhibition of eIF-2 activity, after incubation with
inhibitor and ATP, because such incubation decreased the ac-
tivity of crude but not of purified preparations of eIF-2 (5, 10).
Using the inhibitor assay as a guide, we separated eIF-2 from
X, a factor that enhanced the ability of eIF-2 to form a ternary
complex. However, X did not enhance eIF-2 activity when
inhibitor and ATP were also present. X (ESP) was assayed by
measuring ternary complex formation in each of four samples,
all containing ESP-free eIF-2 and ATP, with the following
reactants: (i) no ESP, no inhibitor; (ii) ESP, no inhibitor; (iii)
no ESP, inhibitor; (iv) ESP, inhibitor. In a typical assay the
amount of ternary complex formed (pmol/50 Al) was as follows:(i) 0.38; (ii) 0.78; (iii) 0.37; (iv) 0.39. Thus, ESP doubled the
amount of complex formed in the absence of inhibitor (ii - i)
and had no effect in the presence of inhibitor (iv - iii). Com-
paring the data in a different-way, inhibitor depressed complex
formation (by 50%) in the presence (ii - iv) but not in the ab-
sence (i - iii) of ESP. Therefore, ESP can be assayed in two
ways. Assay A: inhibition of ternary complex formation by
excess inhibitor plus ATP in samples containing both eIF-2 and
ESP (ii - iv). Assay B: enhancement of ternary complex for-
mation by ESP in samples containing eIF-2 but no inhibitor plus
ATP (ii-i).
To study the effect of the inhibitor on ternary complex for-
mation after allowing it to act separately, rather than simulta-
neously, on eIF-2 and ESP (see legend to Fig. 3B), the ATP was
Abbreviations: Met-tRNAj, initiator species of eukaryotic methionyl-
transfer RNA; cAMP, adenosine 3':5'-cyclic monophosphate; ESP,
eIF-2 stimulating protein; Hepes, N-2-hydroxyethylpiperazine-N'-
l-ethanesulfonic acid.
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FIG. 1. Inhibition of ternary complex formation by reticulocyte
inhibitor (eIF-2 kinase) plus ATP as a function of the concentration
of inhibitor (A) or ofATP (B). (A) ESP-containing eIF-2 DE-180, 34
lg; ATP, 0.4 mM; and various amounts of step 5 inhibitor. (B). eIF-2
CM-400, 3 ug; ESP SE-200, 3.2 Mg; step 5 inhibitor, 0.7 ,g; and various
amounts of ATP. Preincubation with inhibitor and ATP, 2 min; final
incubation, 5 min. Temperature, 300.
removed after preincubation of one or the other factor with
ATP and inhibitor. The samples (175 ,1) were shaken with 20
,ul of a 100 mg/ml suspension of charcoal (charcoal adsorbent,
Radiochemical Centre, Amersham, England) for 30 sec at room
temperature. The charcoal was sedimented by centrifugation
and the samples were processed further as described in the
legend to Fig. SB.
40S complex formation was analyzed by sucrose density
gradient centrifugation essentially as in the one-step procedure
of Nombela et al. (13) with 40S subunits from undeveloped A.
salina embryos (14). Samples (30 Al) containing N-2-hy-
droxyethylpiperazine-N'-l-ethanesulfonate (Hepes) buffer,
pH 7.6, 40 ,uM; KC1, 100 mM; Mg(OAc)2, 10 mM; di-
ethiothreitol, 4 mM; ATP, 0.67 mM; and inhibitor, eIF-2, and
ESP as specified in the legend to Fig. 3C were preincubated
for 2 min at 30°. They were then supplemented with GTP, 0.12
mM final concentration; [asS]Met-tRNAi (12,000-15,000
cpm/pmol), 8 pmol; and 40S subunit, 1.0 A260 unit, and brought
to a final volume of 60 ,1 by addition of enough KCl to make
its final concentration 80 mM. After incubation for 20 min at
300 and 5 min at 00, the samples were processed as described
(13). Protein was determined by the method of Lowry et al. (15)
with bovine serum albumin as the standard.
Preparations. Partially purified inhibitor (eIF-2 kinase) was
prepared from the postribosomal supernatant of commercial
(Gibco) rabbit reticulocyte lysate. The procedure involved
precipitation with ammonium sulfate, chromatography on
DEAE-cellulose [to give a fractiont equivalent to protein kinase
DEAE peak III of Traugh and Traut (16), chromatography on
phosphocellulose, and filtration on Sephadex G-200. (The details
of this procedure will be described elsewhere.) The inhibitor
solution (2 mg of protein per ml) was stored in small aliquots
in liquid nitrogen. The amount of protein required to decrease
protein synthesis in a hemin-containing lysate to the level of
inhibition observed in the absence of hemin (taken as 100%
inhibition) was assumed to contain 1 unit of inhibitor activity.
An amount of inhibitor containing 1.4 Mug of protein caused
100% inhibition in the protein synthesis assay. Its specific ac-
tivity, 714 units/mg of protein, was similar to that of the step
t We are indebted to J. M. Sierra for this material.
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FIG. 2. ESP purification: chromatography on Sephadex G-200.
(Inset) In a separate experiment, a mixture of muscle aldolase (Ald),
ovalbumin (Ova), and ribonuclease A (Rib), molecular weights
152,000, 45,000, and 13,700, respectively, was run on the same column
and the fraction numbers corresponding to the elution peaks of the
three proteins (0) were plotted against molecular weight (X10-5); 0
corresponds to the ESP activity peak in assay A (see Table 1).
4 inhibitor of Ranu and London (12). The preparation of
ESP-free eIF-2 and ESP is described below. Other preparations
and materials were as in previous work (5-7).
RESULTS
Isolation of ESP. ESP and eIF-2 were isolated from the ri-
bosomal salt wash of developing A. salina embryos. Step 1.
Ribosomal wash (11) dialyzed overnight against buffer A [20
mM Hepes, pH 7.6/0.1 mM EDTA/1 mM dithiothreitol/5%
(vol/vol) glycerol] containing 80mM KC1. Step 2. The dialyzed
solution (7.5 ml, 21 mg of protein per ml) was applied to a
DEAE-cellulose (Whatman DE-52, 1.5 X 8 cm) equilibrated
with buffer A containing 80 mM KC1. After the column was
washed with the same buffer, eIF-2 and ESP were eluted with
buffer A containing 180 mM KC1 (DE-180 fraction). Step 3.
The step 2 fraction was applied to a column (0.6 X 8 cm) of
carboxymethyl-Sephadex C-50 (Pharmacia) equilibrated with
buffer A containing 180 mM KC1. This separates eIF-2, which
is retained by the column, from ESP, which is not retained (ESP
CM-180). eIF-2 free from ESP was eluted with buffer A con-
taining 400 mM KC1, yielding 2 ml of solution containing 3 mg
of protein (eIF-2 CM-400). It was stored in small aliquots in
liquid nitrogen. The specific activity of this preparation (ternary
complex assay with excess ESP) was 125 pmol/mg of protein.
Step 4. The protein in the CM-180 effluent fraction was con-
centrated by precipitation with ammonium sulfate between
25 and 80% saturation. The precipitate was dissolved in 2.5 ml
of buffer A, and the solution was dialyzed overnight against the
same buffer. The dialyzed solution was passed through a col-
umn of carboxymethyl-Sephadex C-50 as above, previously
equilibrated with buffer A. ESP (CM-0) is not retained. Step
5. The ESP fraction CM-0 was chromatographed on Sephadex
G-200 (0.9 X 57 cm column) with buffer A as eluent; 0.5-ml
fractions were collected. The bulk of the ESP activity was eluted
in fractions 32-46 (Fig. 2). Fractions 32-41 were pooled to give
a solution containing 1.6 mg of protein per ml (ESP SE-200) and
stored in small aliquots in liquid nitrogen.
A summary of the preparation of ESP is given in Table 1. The
molecular weight of ESP (see Fig. 2) is approximately 180,000.
eIF-2 CM-400 and ESP SE-200 were used throughout the fol-
lowing studies unless otherwise specified.
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Table 1. Purification of ESP from ribosomal salt wadsh
of A. salina embryos
Protein Specific
Step mg Units* activityt
1. Salt wash 160
2. DEAE-cellulose (DE-180) 62
3. FirstCM-Sephadex(CM-180) 37 4100 111
4. Second CM-Sephadex (CM-0) 26 4300 165
5. Sephadex G-200 (SE-200) 8 2500 312
Assay at steps 1 and 2, prior to separation ofESP from eIF-2, was
only qualitative. eIF-2 CM-400 (see text), 6 Ag per sample, was added
for assay at steps 3-5. Assay A (see Materials and Methods) was
used.
* One unit is the amount of protein required to obtain 50% inhibition
of ternary complex formation with purified eIF-2 in the presence
of excess inhibitor and ATP.
t Units/mg of protein.
Effect of ESP and Inhibitor on Initiation Complex For-
mation. Because ESP was isolated as a factor required for in-
hibition of ternary complex formation with purified eIF-2 upon
incubation with inhibitor and ATP, we were surprised to find
(Fig. 3A) that, in the absence of inhibitor, ESP actually stimu-
lated complex formation (bars 1 and 2). In the presence of in-
hibitor and ATP (bars 3 and 4), ESP was without effect. En-
hancement of the activity of eIF-2 by ESP probably involves
interaction of the two factors. Hence, blocking of this interac-
tion could be caused by (i) phosphorylation of the 38,000-dalton
subunit of eIF-2 alone, (ii) phosphorylation of ESP alone, or (i )
phosphorylation of both eIF-2 and ESP. Fig. 3B shows that
explanation (i) is the correct one. Here, either eIF-2 or ESP was
first preincubated with ATP, with or without inhibitor, and the
ATP was then removed with charcoal. The samples were then
supplemented with the missing factor (ESP or eIF-2) together
with GTP and [35S]Met-tRNAj and incubated further for ter-
nary complex formation. Exposure of eIF-2 alone to inhibitor
and ATP blocked its interaction with ESP (Fig. 3B, bars A and
B) but the same treatment of ESP alone did not affect its in-
teraction with eIF-2 (Fig. 3B, bars C and D). Comparison of
black bars in A and B and the corresponding ones in C and D
show that ATP was effectively removed by the charcoal
treatment, because inhibitor was without effect unless ATP was
added again. Fig. 3C and D show that what is true of ternary
complex is also true of 40S initiation complex formation. Thus,
with ESP-containing eIF-2, formation of 40S complex was
decreased when the samples contained inhibitor and ATP (Fig.
SC, bars 1 and 2). With ESP-free eIF-2, ESP stimulated 40S
complex formation in the absence (Fig. 3C and D, bars and
samples 3 and 4) but not in the presence (bars and samples 5 and
6) of inhibitor and ATP.
The enhancement of ternary complex formation by eIF-2
in the presence of increasing concentrations of ESP is shown
in Fig. 4A. Note that no complex was formed when ESP was
present without either GTP or eIF-2. The kinetics of ternary
complex formation with and without ESP and/or inhibitor plus
ATP are shown in Fig. 4B. Maximal complex formation re-
quired 5-7 min. ESP increased not only the extent but also the
rate of complex formation. Again, inhibitor plus ATP had no
effect in the absence of ESP but virtually abolished the ability
of the latter to enhance complex formation. ESP enhanced
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FIG. 3. Effect ofESP and inhibitor on initiation complex formation. (A) Effect on ternary complex formation. ATP (0.4 mM) and eIF-2 (6
Mg) were present throughout. Other reactants, when present, were: ESP, 6 Mg; inhibitor, 0.7 ,ug. Bars: 1, eIF-2; 2, eIF-2 and ESP; 3, eIF-2 and
inhibitor; 4, eIF-2, inhibitor, and ESP. (B) Inhibition of ESP effect on ternary complex formation requires interaction of inhibitor and ATP
with eIF-2 only. Samples (175 Ml) containing either 35kug of eIF-2 (bars A and B) or 24 ig of ESP (bars C and D) were preincubated with 0.057
mM ATP (bars A and C) or with 0.057 mM ATP and 3.5 Mg of inhibitor (bars B and D) for 6 min at 300. Other components present in all samples
during preincubation were Hepes buffer, pH 7.6,28.5 mM; Mg(OAc)2, 4.3 mM; KCl, 68.5 mM; and dithiothreitol, 2.8 mM. The ATP was removed
with charcoal. Aliquots (35 gl) of the supernatant were supplemented with GTP, 0.14 mM, and [35S]Met-tRNAi (25,000 cpm/pmol), 1.8 pmol,
plus the following additions: In A, o none, a ESP (3.2 ig), U ESP (3.2 ig) and inhibitor (0.7 ag); in B, a none, a ESP (3.2 Mg), U ESP (3.2 Mg),
inhibitor (0.7 Mg), and ATP (0.04 mM); in C, o none, 9 eIF-2 (5 jg), * eIF-2 (5 gg) and inhibitor (0.7 Mg); in D, o none, 0 eIF-2 (5Mtg), * eIF-2(5Mug), inhibitor (0.7 ig), and ATP (0.04 mM). Final volume, 50 Ml. After incubation for 5 min at 300 the samples were assayed for ternary complex
formation. The concentration of the other components present in all samples during the final incubation were: Hepes buffer, pH 7.5, 20 mM;
Mg(OAc)2, 3 mM; KCl, 100 mM; and dithiothreitol, 2 mM. (C) Effect on 40S complex formation. Samples 1 and 2 had ESP-containing eIF-2
DE-180, 51 Mg; samples 3-6 had eIF-2 CM-400, 18Mig. Other reactants, when present, were: ESP, 12 ,g, and/or inhibitor, 2 ,g in sample 2 or 1
Mgg in samples 5 and 6. Bars: 1, eIF-2; 2, eIF-2 and inhibitor; 3, eIF-2; 4, eIF-2 and ESP; 5, eIF-2 and inhibitor; 6, eIF-2, inhibitor, and ESP. (D)
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FIG. 4. (A). Ternary complex formation as a function of the concentration of ESP. Samples containing GTP and [36S]Met-tRNAi were
incubated with the amounts of eIF-2 indicated below and increasing amounts of ESP for 5 min at 300 and assayed for ternary complex formation.
0, eIF-2, 3Mgg; *, eIF-2, 6,Mg. *, eIF-2, 6Mug; ESP, 3.2,Mg; no GTP. A, No eIF-2; ESP, 4.8,Mg. (B). Kinetics of ternary complex formation in the
absence or present of ESP and/or inhibitor. Samples containing GTP, [35S]Met-tRNAi, eIF-2 (3 Mg)' and other additions as indicated below
were incubated for various times at 300 and assayed for ternary complex formation. 0, ATP, 0.4 mM; 0, ATP, 0.4 mM, and ESP, 3.2,Mg; o, ATP,
0.4 mM, and inhibitor, 0.7 Mig; *, ATP, 0.4 mM, inhibitor, 0.7 jg, and ESP, 3.2 gg.
ternary complex formation as much as 20-fold at low eIF-2
concentrations but was virtually without effect at high con-
centrations (Table 2). We have also isolated from rabbit retic-
ulocyte lysate by the same procedure used for the A. salina
factors, eIF-2 and ESP free from each other and have obtained
similar results. Moreover, reticulocyte eIF-2 interacted with
A. salina ESP and conversely (unpublished data).
Sensitivity of ESP to SH-Binding Reagents. ESP was as
sensitive as eIF-2 (11, 17, 18) to SH-binding reagents (Table 3).
N-Ethlymaleimide at 20 mM or p-chloro-mercuribenzene-
sulfonic acid at 1.0 mM inhibited ESP stimulation of ternary
complex formation by more than 80%; 2.0 mM p-chloromer-
curibenzenesulfonic acid inhibited ESP and eIF-2 activity to
the same extent, 95%.
DISCUSSION
The activity of a ribosomal wash factor that enhances the ability
of eIF-2 to form ternary or 40S initiation complexes is abolished
by incubation of eIF-2 with inhibitor and ATP. We call the new
factor "ESP" for "eIF-2 stimulating protein." Its molecular
weight is approximately 180,000 and, like eIF-2, it has SH
groups that are essential for activity. The effect of ESP on ter-
nary complex formation is similar to that of a factor described
by Dasgupta et al. (19). Incubation of eIF-2 with eIF-2 kinase
and ATP is without effect on complex formation (whether
ternary or 40S) unless ESP is present. A report that phospho-
rylation of eIF-2 inhibited 40S but not ternary complex for-
mation (20) can be explained by the fact that ternary complex
Table 2. Effect of ESP on ternary complex formation at different
eIF-2 concentrations
[35S]Met-tRNAi in ternary complex, Stimulation
eIF-2 pmol by ESP,
Mg/50 l Without ESP With ESP -fold
0.24 0.0002 0.004 20
0.60 0.001 0.02 20
1.2 0.015 0.07 5
2.4 0.05 0.16 3
4.8 0.18 0.34 2
7.2 0.29 0.47 1.6
10.8 0.48 0.57 1.2
Standard assay with 3 pmol of high specific radioactivity [355]-
Met-tRNA; (104,600 cpm/pmol), the indicated amounts of eIF-2, and
when present, 3.2 Mg of ESP.
formation was assayed in the presence of an additional ribo-
somal wash fraction that probably contained ESP. It could be
argued that ESP might be contaminated with a factor that in-
activates phosphorylated eIF-2, the kind of factor that we
originally set out to isolate. We think that is unlikely because
the ratio of stimulation of complex formation by ESP to inhi-
bition of complex formation by eIF-2 kinase plus ATP in the
presence of ESP remained constant (i) on purification, (ii) on
heating at various temperatures, (iii) on exposure to different
concentrations of -SH binding reagents, and (iv) over a wide
range of ESP concentrations (data not shown).
Table 3. Sensitivity of ESP and eIF-2 to SH-binding reagents
Ternary complex formation
ESP treated eIF-2 treated
Due to ESP, Inhibi- Total, Inhibi-
Treatment pmol tion, % pmol tion, %
Control 0.23
N-Ethylmaleimide:
1mM 0.15 35
5 mM 0.07 69
20 mM 0.04 83
20 mM plus
dithiothreitol, 40 mM 0.23 0
Control 0.27 0.16
p-Chloromercuriben-
zenesulfonic acid:
0.1 mM 0.25 7
0.5 mM 0.20 26 0.13 19
1.0 mM 0.03 89
2.0 mM 0.01 96 0.01 94
2.0 mM plus
dithiothreitol, 10 mM - 0.16 0
ESP or eIF-2 was preincubated without or with N-ethylmaleimide
or p-chloromercuribenzenesulfonate at the stated concentrations for
15 min at 250: after the unreacted reagent was neutralized with excess
dithiothreitol (20 or 10 mM, respectively), the activity of the factors
in ternary complex formation was assayed. Controls were run in which
excess dithiothreitol was present during preincubation of the factors
with the SH-binding reagent. In the ESP sensitivity tests, the samples
contained 3 gg of eIF-2 and 3.2 gg of ESP; in the eIF-2 sensitivity tests
they contained 3,ug of eIF-2 but no ESP. Values are given in pmol of[35SJMet-tRNA; in ternary complex. In the ESP experiments, the
difference between samples with ESP and a control without ESP-
i.e., the stimulation of ternary complex formation by ESP-is
given.
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At the concentrations routinely used in this work, eIt-P was
able to form an initiation complex in the absence of ESP;
complex formation was increased 2- to-&fold by ESP. However,
at low eIF-2 concentrations (0.24-0.6 Ag of eIF-2 CM-400 per
50,il), ESP stimulated complex formation as much as 20-fold.
We have determined the eIF-2 content of rabbit reticulocyte
lysates and have estimated that protein synthesis assay samples
(50 ,il, 25 Mil of lysate) contain the equivalent of about 0.4 ,Ag of
eIF-2 CM-400. At this concentration (see Table 2), the ability
of eIF-2 to form a ternary complex is almost negligible in the
absence of ESP. Because the effect of ESP is prevented by in-
cubation of eIF-2 with inhibitor and ATP, the observations
reported in this paper fully elucidate the mechanism by which
phosphorylation of the eIF-2 present in reticulocyte lysates
inhibits chain initiation. They also explain why addition of large
amounts of eIF-2 relieves this inhibition (9). The following
model for the mode of action of ESP is consistent with our ob-
servations. ESP complexes with eIF-2 (reaction 1), but not with
phosphorylated eIF-2 (reaction 2), whereby the equilibrium
of reaction 3 is displaced toward ternary complex formation
(reaction 4).
eIF-2 + ESP,[eIF-2 - ESP] [1]
eIF-2(P) + ESP-;[eIF-2(P) * ESP] [2]
eIF-2 + GTP + Met-tRNA1=eIF-2 - GTP * Met-tRNAi
[3]
[eIF-2 - ESP] + GTP [4]
+ Met-tRNAj [eIF-2 - ESP] - GTP - Met-tRNAj
A better understanding of the properties of ESP must await
further purification of this protein.
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